These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28860222)

  • 21. Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study.
    Kwon S; Lee SR; Choi EK; Lee SH; Han KD; Lee SY; Yang S; Park J; Choi YJ; Lee HJ; Moon I; Lee E; Cha MJ; Lim WH; Oh S
    Int J Cardiol; 2019 Oct; 293():153-158. PubMed ID: 31253527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
    Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
    Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of Retinal Vein Occlusion in Patients With End-Stage Renal Disease: A 12-Year, Retrospective, Nationwide Cohort Study in South Korea.
    Lee KS; Nam KH; Kim DW; Kang EC; Koh HJ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):39-44. PubMed ID: 29302692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
    Chang TI; Tabada GH; Yang J; Tan TC; Go AS
    J Hypertens; 2016 Feb; 34(2):244-52. PubMed ID: 26599220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
    Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
    PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.
    Lin WY; Liang FW; Lu TH
    PLoS One; 2015; 10(5):e0126965. PubMed ID: 25993556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in metabolic parameters and risk of dementia: a nationwide population-based study.
    Lee SH; Han K; Cho H; Park YM; Kwon HS; Kang G; Yoon KH; Kim MK
    Alzheimers Res Ther; 2018 Oct; 10(1):110. PubMed ID: 30368247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between dyslipidemia and the risk of developing end-stage renal disease in a screened cohort.
    Iseki K; Tozawa M; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2005 Mar; 9(1):46-52. PubMed ID: 15830273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009.
    Chang YT; Wu JL; Hsu CC; Wang JD; Sung JM
    Diabetes Care; 2014; 37(1):277-85. PubMed ID: 23920086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT.
    Whittle J; Lynch AI; Tanner RM; Simpson LM; Davis BR; Rahman M; Whelton PK; Oparil S; Muntner P
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):471-80. PubMed ID: 26912544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.
    Bostom AG; Shemin D; Verhoef P; Nadeau MR; Jacques PF; Selhub J; Dworkin L; Rosenberg IH
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2554-8. PubMed ID: 9409227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
    Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study.
    Lee SR; Choi EK; Rhee TM; Lee HJ; Lim WH; Kang SH; Han KD; Cha MJ; Cho Y; Oh IY; Oh S
    Int J Cardiol; 2016 Nov; 223():953-957. PubMed ID: 27589043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anthropometric and Metabolic Risk Factors for ESRD Are Disease-Specific: Results from a Large Population-Based Cohort Study in Austria.
    Zitt E; Pscheidt C; Concin H; Kramar R; Lhotta K; Nagel G
    PLoS One; 2016; 11(8):e0161376. PubMed ID: 27537361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland.
    Kastarinen M; Juutilainen A; Kastarinen H; Salomaa V; Karhapää P; Tuomilehto J; Grönhagen-Riska C; Jousilahti P; Finne P
    J Intern Med; 2010 Jun; 267(6):612-20. PubMed ID: 20210838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study.
    Lee CF; Lin CL; Lin MC; Lin SY; Sung FC; Kao CH
    J Periodontol; 2014 Jan; 85(1):50-6. PubMed ID: 23646848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer in Korean patients with end-stage renal disease: A 7-year follow-up.
    Yoo KD; Lee JP; Lee SM; Park JY; Lee H; Kim DK; Kang SW; Yang CW; Kim YL; Lim CS; Joo KW; Kim YS
    PLoS One; 2017; 12(7):e0178649. PubMed ID: 28692695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.